Analysts think ALVO stock price could increase by 84%
Dec 14, 2025, 12:26 PM
0.00%
What does ALVO do
Alvotech is a global biopharmaceutical company focused on developing biosimilar medicines, with eight candidates targeting various therapeutic areas. Key products include AVT02 (biosimilar to Humira) and AVT04 (biosimilar to Stelara).
7 analysts think ALVO stock price will increase by 83.95%. The current median analyst target is $10.20 compared to a current stock price of $5.54. The lowest analysts target is $8.08 and the highest analyst target is $10.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.